Trial intelligence / Profile preview

Magnesium Sulfate with Therapeutic Hypothermia for Neonatal Encephalopathy

NCT02499393Phase 3Completed

Sponsor
Instytut Centrum Zdrowia Matki Polki
Start
Apr 2010
Primary completion
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of magnesium sulfate in hypoxic-ischemic encephalopathy (HIE), sponsored by Instytut Centrum Zdrowia Matki Polki. Started Apr 2010; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

hypoxic-ischemic encephalopathy (HIE)

Beyond the preview

Go deeper on NCT02499393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02499393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call